Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer
José Rodrigues Pereira, Maximiliano Van Kooten(Universidad Abierta Interamericana), Gilberto Schwartsmann(Universidade Luterana do Brasil), Teena West, Luis Fein(National Cancer Center), Eduardo Richardet(Instituto Oncológico de Córdoba), Auro del Giglio(Faculdade de Medicina do ABC), C. Blajman, Belinda J. Hall(Union Hospital), Mauro Orlando(Instituto Alexander Fleming)
Cited by 11
Related Papers
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications
|Photodiagnosis and Photodynamic Therapy|2005|910
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
|Journal of Clinical Oncology|2007|483
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
|Journal of Clinical Oncology|2011|479
The biology of cancer-related fatigue: a review of the literature
|Supportive Care in Cancer|2015|305